Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India
Shots: The company reported the positive results of the initial trial for Zofin in the first 10 COVID-19 patients treated with Zofin in India. The […]
Shots: The company reported the positive results of the initial trial for Zofin in the first 10 COVID-19 patients treated with Zofin in India. The […]
Shots: The acquisition expands SparingVision’s ocular genomic medicine pipeline with the addition of GAMUT’s lead product SPVN20, which is a novel, mutation-agnostic gene therapy, focuses […]
Shots: Pear collaborates with Empatica, etectRx and KeyWise to bolster its PDT platform with digital biomarkers, machine learning algorithms, sensor-based technologies, and digital therapeutics The […]
Shots: The companies expanded the collaboration to improve health for people with T2D. The agreement integrates the Dexcom G6 CGM system and Welldoc’s BlueStar digital […]
Shots: The companies plan to initiate a P-IIb study assessing NovoNordisk’s semaglutide and FD combination of Gilead’s cilofexor + firsocostat vs PBO in ~440 patients […]
Shots: The companies plan to initiate a P-IIb study assessing NovoNordisk’s semaglutide and FD combination of Gilead’s cilofexor + firsocostat vs PBO in ~440 patients […]
Shots: Cheplapharm to pay AstraZeneca a total of $400M non-contingent consideration, present value recognised as other operating income upon completion of the transaction, anticipated during […]
Shots: StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across […]
Shots: Synaffix to receive upfront, milestone and royalty payments tied to each program while ADC gets a non-exclusive right for two additional programs, bringing the […]
Copyright © 2024 | WordPress Theme by MH Themes